{"id":406441,"date":"2025-09-15T00:30:00","date_gmt":"2025-09-14T22:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/enfoques-terapeuticos-basados-en-la-patogenesis-y-nefroprotectores\/"},"modified":"2025-09-15T14:08:15","modified_gmt":"2025-09-15T12:08:15","slug":"enfoques-terapeuticos-basados-en-la-patogenesis-y-nefroprotectores","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/enfoques-terapeuticos-basados-en-la-patogenesis-y-nefroprotectores\/","title":{"rendered":"Enfoques terap\u00e9uticos basados en la patog\u00e9nesis y nefroprotectores"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>La nefropat\u00eda por inmunoglobulina (Ig) A se considera una causa importante de insuficiencia renal terminal. Por lo tanto, desde la perspectiva actual, la nefropat\u00eda por IgA no debe considerarse una enfermedad benigna. Afortunadamente, el espectro terap\u00e9utico se ha ampliado en los \u00faltimos a\u00f1os. Adem\u00e1s de la TRF-budesonida oral y el f\u00e1rmaco DEARA esparsentan, que ya han sido autorizados en muchos pa\u00edses, actualmente se est\u00e1n desarrollando numerosas terapias basadas en la patog\u00e9nesis. Sin embargo, las opciones terap\u00e9uticas nefroprotectoras cl\u00e1sicas &#8211; RAAS-i, SGLT-2-i, ARM y GLP-1-RA &#8211; tambi\u00e9n siguen desempe\u00f1ando un papel importante.    <\/strong>.<\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fenfoques-terapeuticos-basados-en-la-patogenesis-y-nefroprotectores%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>La nefropat\u00eda por inmunoglobulina (Ig) A se considera una causa importante de insuficiencia renal terminal. Por lo tanto, desde la perspectiva actual, la nefropat\u00eda por IgA no debe considerarse una&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fenfoques-terapeuticos-basados-en-la-patogenesis-y-nefroprotectores%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":126521,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Glomerulonefritis: Nefropat\u00eda IgA  ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11552,11483,11475,11408,11358,11288,11377],"tags":[84392,84395,63880,65639,68408,77592,22916,18648,84393,84394],"powerkit_post_featured":[],"class_list":["post-406441","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-es","category-el-congreso-informa","category-estudios","category-farmacologia-y-toxicologia","category-gastroenterologia-y-hepatologia","category-medicina-interna-general","category-nefrologia","tag-deara-es","tag-enfoques-terapeuticos-es","tag-glomerulonefritis-es","tag-glp-1-ra-es-2","tag-mra-es","tag-nefropatia-iga","tag-nefroproteccion","tag-sglt-2-i-es","tag-sparsentan-es","tag-trf-budesonida","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-24 01:28:08","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/406441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=406441"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/406441\/revisions"}],"predecessor-version":[{"id":408756,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/406441\/revisions\/408756"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/126521"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=406441"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=406441"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=406441"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=406441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}